A Real-World Evidence Study Using Alberta-Population-Based Data to Describe Treatment Patterns for Metastatic Castration-Sensitive Prostate Cancer Patients (AWARENESS)

Introduction: Over the past decade, the treatment of metastatic castration-sensitive prostate cancer (mCSPC) has changed significantly. Current guidelines suggest the use of androgen deprivation therapy (ADT) plus an additional systemic therapy, regardless of disease burden and risk, based on phase...

Full description

Bibliographic Details
Main Authors: Safiya Karim, Jennifer Lowther, Gabriel Gyulay, Dylan O’Sullivan, Christopher J. D. Wallis, Steven M. Yip, Darren R. Brenner, Devon J. Boyne, Winson Y. Cheung
Format: Article
Language:English
Published: MDPI AG 2023-09-01
Series:Current Oncology
Subjects:
Online Access:https://www.mdpi.com/1718-7729/30/9/591